Table 1.

Characteristics of the study group

No. of patients	26
Female sex (%)	13 (50)
Age, year (median, range)	66 (37–83)
BMI (mean, SD)	23.9 ± 3.5
Smoker (%)	6 (23)
History of diabetes (%)	9 (35)
Dialysis vintage, month (median, range)	10 (6–37)
Laboratory parameters
fS-calcium-ion 1.16–1.13 mmol/l (median, IQR)	1.17 (1.11–1.23)
fP-phosphorus 0.71–1.23 mmol/l (median, IQR)	1.61 (1.41–1.99)
fP-PTH 15–65 ng/l (median, IQR)	285 (178–537)
P-D-25 > 50 nmol/l (median, IQR)	70 (40–94)
S-D-125 37–216 pmol/l (median, IQR)	30 (24–58)
P-tALP 35–105 U/l (median, IQR)	88 (67–132)
P-Alb 36–45 g/l (median, IQR)	31.9 (27.8–33.6)
Medication
Calcimimetic (%)	4 (15)
Alfacalcidol, Paricalcitol (%)	14 (58)
Calcium carbonate (%)	22 (85)
Cholecalciferol (%)	23 (88)
Sevelamer/lantane carbonate (%)	16 (62)
Corticosteroid (%)	2 (8)